389 related articles for article (PubMed ID: 2997275)
21. Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis.
Vlodavsky I; Fuks Z; Bar-Ner M; Ariav Y; Schirrmacher V
Cancer Res; 1983 Jun; 43(6):2704-11. PubMed ID: 6601984
[TBL] [Abstract][Full Text] [Related]
22. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix.
Fridman R; Lider O; Naparstek Y; Fuks Z; Vlodavsky I; Cohen IR
J Cell Physiol; 1987 Jan; 130(1):85-92. PubMed ID: 2433294
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
24. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.
Bame KJ; Danda J; Hassall A; Tumova S
J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014
[TBL] [Abstract][Full Text] [Related]
25. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
[TBL] [Abstract][Full Text] [Related]
26. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
Hoogewerf AJ; Leone JW; Reardon IM; Howe WJ; Asa D; Heinrikson RL; Ledbetter SR
J Biol Chem; 1995 Feb; 270(7):3268-77. PubMed ID: 7852412
[TBL] [Abstract][Full Text] [Related]
27. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate.
Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T
J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189
[TBL] [Abstract][Full Text] [Related]
28. Regulation of platelet heparanase during inflammation: role of pH and proteinases.
Ihrcke NS; Parker W; Reissner KJ; Platt JL
J Cell Physiol; 1998 Jun; 175(3):255-67. PubMed ID: 9572470
[TBL] [Abstract][Full Text] [Related]
29. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules.
Ihrcke NS; Platt JL
J Cell Physiol; 1996 Sep; 168(3):625-37. PubMed ID: 8816917
[TBL] [Abstract][Full Text] [Related]
30. Maintenance on extracellular matrix and expression of heparanase activity by human ovarian carcinoma cells from biopsy specimens.
Peretz T; Antebi SU; Beller U; Horowitz AT; Fuks Z; Vlodavsky I
Int J Cancer; 1990 Jun; 45(6):1054-60. PubMed ID: 2190937
[TBL] [Abstract][Full Text] [Related]
31. Degradation of basement membrane by prostate tumor heparanase.
Kosir MA; Wang W; Zukowski KL; Tromp G; Barber J
J Surg Res; 1999 Jan; 81(1):42-7. PubMed ID: 9889056
[TBL] [Abstract][Full Text] [Related]
32. [Human heparanase: roles in invasion and metastasis of cancer].
Gohji K; Katsuoka Y; Okamoto M; Kamidono S; Kitazawa S; Toyoshima M; Dong J; Nakajima M
Hinyokika Kiyo; 2000 Oct; 46(10):757-62. PubMed ID: 11215206
[TBL] [Abstract][Full Text] [Related]
33. Subendothelial extracellular-matrix heparan sulfate proteoglycan-degrading activity of human monocyte macrophages.
Shimada K; Ozawa T
Heart Vessels; 1987; 3(4):175-81. PubMed ID: 2969381
[TBL] [Abstract][Full Text] [Related]
34. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase.
Nakajima M; Irimura T; Di Ferrante N; Nicolson GL
J Biol Chem; 1984 Feb; 259(4):2283-90. PubMed ID: 6698965
[TBL] [Abstract][Full Text] [Related]
35. Human platelet heparanase: purification, characterization and catalytic activity.
Freeman C; Parish CR
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1341-50. PubMed ID: 9494105
[TBL] [Abstract][Full Text] [Related]
36. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
Marchetti D; Nicolson GL
Adv Enzyme Regul; 1997; 37():111-34. PubMed ID: 9381967
[TBL] [Abstract][Full Text] [Related]
37. Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis.
Vlodavsky I; Korner G; Ishai-Michaeli R; Bashkin P; Bar-Shavit R; Fuks Z
Cancer Metastasis Rev; 1990 Nov; 9(3):203-26. PubMed ID: 1705486
[TBL] [Abstract][Full Text] [Related]
38. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.
Whitelock JM; Murdoch AD; Iozzo RV; Underwood PA
J Biol Chem; 1996 Apr; 271(17):10079-86. PubMed ID: 8626565
[TBL] [Abstract][Full Text] [Related]
39. Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts.
Goshen R; Hochberg AA; Korner G; Levy E; Ishai-Michaeli R; Elkin M; de Groot N; Vlodavsky I
Mol Hum Reprod; 1996 Sep; 2(9):679-84. PubMed ID: 9239682
[TBL] [Abstract][Full Text] [Related]
40. Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils.
Mollinedo F; Nakajima M; Llorens A; Barbosa E; Callejo S; Gajate C; Fabra A
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):917-23. PubMed ID: 9581574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]